Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus (IMAGINE 5)
This study is ongoing, but not recruiting participants.
Study NCT01582451   Information provided by Eli Lilly and Company

First Received on April 19, 2012.   Last Updated on February 1, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type 2
Additional conditions recognized in this trial
Diabetes Mellitus
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
LY2605541
Insulin glargine
Additional drug interventions recognized in this trial
Glargine
Hypoglycemic Agents
Insulin
Insulin, Long-Acting
More general drug interventions related to this trial
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Eli Lilly and Company
Boehringer Ingelheim Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services